Omrix Biopharmaceuticals, Inc. (OMRI)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Omrix Biopharmaceuticals, Inc. (OMRI)
28 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on OMRI
- Shlomi Cohen(11)
- Shlomo Greenberg(2)
- Aaron Katsman(2)
- Centient Biotech Investor(2)
- Brian Orelli(2)
Most popular authors
(tracked in watchlists)
- SA Editor Rachael Granby(247)
- Mike Havrilla(160)
- Notable Calls(111)
- Mike Huckman(75)
- Shlomi Cohen(52)
Most commented on authors
- Shlomi Cohen(11)
- SA Editor Rachael Granby(9)
- Eben Tessari (2)
- Mike Huckman(2)
- Dan Rosenblum (1)
- Israeli M&A Market Heats Up as St. Jude Medical Acquires MediGuide
- 40 Top Rated Emerging Bio-Pharma Stocks
- Nine Pharma Predictions for 2009
- Wall Street Breakfast: Must-Know News
- JNJ / Omrix: Potential Synergies
- Why Smaller Is Better: RRsat, EZchip
- Falling Apart Over Omrix; Can Some Telcos Gain from the Current Crisis?
- Omrix & SanDisk: Takeover Talk Drives Volatile Trading
- Omrix Stops the Bleeding; Has SanDisk Started Healing?
- Small Caps Bounce High; Who Will Buy Metalink?
- Omrix and RR Satellite: Fallen, But Potentially Mighty
- WiMAX Doubts Dispelled, Alvarion Spikes; Is Omrix Back?
- If We Sell on Good News, When Do We Buy?
- Insider Buying in Biotech Land
- Why I Am Adding Sandisk & Ceragon To My Portfolio
- Omrix Biopharma Is Sure To Bounce Following Pre-Market Selloff
- Another Disappointing Quarter for Omrix Biopharmaceuticals
- Cutting My Apple, Omrix, and SanDisk to Make Way For Sigmatel and Orckit
- Omrix Biopharmaceuticals: Passive Immunotherapy Beat Biosurgery Sales
- Omrix’s Biosurgical Patches Help Stop The Bleeding
- Rough Week for Biotech
- 2007: The Year Of Biotech IPOs?
- Omrix's Secondary May Make It A Buy
- Omrix Undervalued After Outstanding Quarter
- Hezbollah Rockets and SEC Filings: 'Duck & Cover!'
- Omrix Biopharm Has What It Takes (OMRI)
- Amicus IPO: A Very Risky Prospect (AMTX)
- Omrix Biopharmaceuticals IPO Analysis (OMRI)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »